These findings provide evidence that damaged motoneurons require limited and spatially directed amounts of BDNF and GDNF to support their survival and regeneration. Moreover, neurotrophic support appears to be needed only for a critical period of time not longer than for two weeks after injury.
Introduction
Plexus injuries in humans usually involve the avulsion of one or more ventral roots (Millesi 1992 , Bertelli and Ghizoni 2003 , Gilbert et al. 2006 . Experimental ventral root avulsion in animals mimics the features of proximal plexus lesions in humans, resulting in degeneration and later loss of the affected motoneurons in the ventral horn and atrophy of the target muscles (Koliatsos et al., 1994) . Reimplantation of the avulsed ventral root in the spinal cord increases the survival rate of the affected motoneurons, but promotes only limited reinnervation by the motor axons (Carlstedt et al. 1986 , Nógrádi and Vrbová 1996 , Eggers et al. 2010 ).
Several attempts have been made to improve the extent of reinnervation by surviving motoneurons after ventral root avulsion and reimplantation. The use of riluzole (a compound that blocks voltage-gated sodium and calcium channels and inhibits presynaptic glutamate release) after experimental root avulsion and reimplantion of the L4 ventral root, dramatically improved survival of injured motoneurons, accompanied by an extensive axonal regeneration resulting in solid reinnervation (up to 65%) of the target denervated muscles Vrbová 2001, Nógrádi et al. 2007 ). Local application of recombinant GDNF, a member of the transforming growth factor beta family induced rescue of the injured motoneurons and satisfactory reinnervation of the target muscle when applied in co-treatment with riluzole (Bergerot et al. 2004) . Other strategies involved the use of progenitor and stem cells in the vicinity of the reimplanted ventral root (Hell et al. 2009 , Su et al. 2009 , Bonner et al. 2010 .
Although satisfying survival of the injured motoneurons could be achieved, all these strategies failed to induce functional regeneration of the target muscles.
Neurotrophic factors mediate survival, differentiation, neurite outgrowth and functional plasticity in the central and peripheral nervous system. In vitro and in vivo experiments confirm the promoting effects of neurotrophic factors (BDNF, NT3, NT4/5) on motoneuron survival (Henderson et al. 1993 , Li et al 1994 . The presence of messenger RNA coding for neurotrophic factors at appropriate stages in spinal cord and limb bud development and mRNA for their receptors on the motoneurons emphasize the high impact of neurotrophins in a certain time windows of embryonic development of the spinal motoneurons (Henderson et al. 1993 ).
GDNF and and other neurotrophic factors (BDNF, NT-3,NT-4/5) support motoneuron survival under several experimental conditions (Oppenheim et al. 1992 , Henderson et al. 1994 , Wu et al. 1995 , Vejsada et al. 1995 , 1998 Kishino et al. 1997 , Novikova et al. 1995 , Wiese et al. 1999 , Boyd, JG. T. Gordon T. 2001 . On the other hand, their use failed in the cases of promoting motoneuron axonal regeneration after avulsion injuries. Blits et al. (2004) injected GDNF-inducing Adeno-associated Virus (AAV) into the injured spinal cord segment. Although this treatment resulted in good motoneuron survival, no functional reinnervation was achieved. Similarly, the same group (Eggers et al. 2008) tried to induce reinnervation of reimplanted ventral root and peripheral targets with direct injection of lentivirus inducing the expression of GDNF in the reimplanted ventral root, without success to induce elongative growth of the regenerating motor axons. The side effect of this uncontrolled and persistent virus-based production of neurotrophic factors at the site of injury was formation of irregular coils of sprouting axons, likely due to the so called "candy store" trapping effect of neurotrophic factors on the injured axons. Recent efforts to establish a gradient of neurotrophins along the injured sciatic nerve to force axons to grow along the whole length of the nerve have proven unsuccessful. The likely reason for this could be that even the lowest dose of viral constructs applied prohibited axonal growth and myelination of the coil-forming axons (Eggers et al. 2013) .
Based on the above data it can be hypothesized that by reducing the amount, duration and location of neurotrophic factor overexpression after ventral root avulsion, the axons of injured motoneurons will be attracted to the site of neurotrophic factor application but will not be trapped there. The aim of the present study is to establish conditions by applying non-viral gene therapy, enabling regenerating motor axons of surviving motoneurons to follow an elongative growth pattern and reinnervate the denervated hind limb muscles.
Material and Methods

Isolation and culturing of rat adipose derived stem cells
Epididymal fat pads were isolated aseptically from male Sprague-Dawley rats under terminal anaesthesia and transferred into 60 ml sterile PBS for further dissection. All subsequent steps were carried out in a vertical laminar flow box to avoid infection.
The fat pads were cut into small pieces and blood vessels were removed. Tissue pieces were washed twice with PBS followed by digestion in 10 ml of 1.5 mg/ml collagenase 1 solution (Worthington Biochemical Co., Lakewood, NJ, USA) for 30 min at 37°C and 180 U/min shaking. The digested tissue was filtered through a 100 µm cell strainer and transferred into 50 ml Falcon tubes. Following centrifugation for 7 min at 400g at room temperature, the supernatant was discarded and the pellets were washed by re-suspension and centrifugation (400g, RT) in 1x PBS. The rASCs were re-suspended in 5ml rASC-medium (DMEM high glucose, 1% Penicillin/Streptomycin, 1% glutamine, 10% fetal calf serum [FCS] ) and brought into culture in 75cm 2 flasks. Aliquots of 1x10 6 cells/ml in DMEM (5% FCS) with 10% dimethylsulfoxide (DMSO) were made and stored in liquid nitrogen.
Frozen aliquots were thawed on 37°C before re-culturing and centrifuged for 5 min at 400g. Cells were resuspended in fresh medium and sewn in 175ml flasks. After 24h the medium was changed for further cultivation.
Cell staining with Cellbrite
In order to track rASCs after transplantation, the cells were labelled using the Cellbrite TM Red Cytoplasmic Membrane Staining Kit (Biotium CA, USA). The overall labelling efficacy was approximately 95%. Cells were trypsinized and suspended at a density of 1x10 6 /ml in serumfree DMEM. After adding 5µl of cell-labeling solution per 1ml of cell suspension, the cells were incubated at 37° for 20 minutes. After a centrifugation step for 5 min at 1500 rpm at 37°, the supernatant was removed and cells were gently resuspended in warm (37°) medium.
Following two more washing steps (centrifugation and resuspension), cells were resuspended in serum free DMEM at a concentration of 1x10 6 /ml for further in vivo use.
Design of pVAX1-rBDNF and pVAX1-mGDNF vectors
cDNA sequences for rat BDNF and mouse GDNF were purchased from Open Biosystems/Thermo Scientific (Pittsburgh, PA, USA). Both genes were amplified by using Taq-polymerase. Primers were designed to introduce a Kozak translation initiation sequence as well as specific restriction sites for further cloning into pVAX1 (Life Technologies, Paisley, UK). pVAX1 is a DNA vaccination plasmid vector designed for high-level transient expression. The resulting pVAX1-rBDNF and pVAX1-mGDNF plasmids (Fig. 1A-B was changed 4 hours after transfection to reduce cytotoxic effects of cationic liposomes. The DNA: Lipofectamine 2000 ratio of 1:1 was chosen in order to achieve maximum transfection rate at low cytotoxicity, based on our previous experience (data not shown).
Evaluation of transgene expression: Enzyme linked immuno-sorbent assay (ELISA)
The expression kinetics of therapeutic transgenes were evaluated by the ELISA technique (Boster Biological Technology Ltd, Fremont, CA, USA). BDNF or GDNF polyclonal antibodies were used to pre-coat 96-well plates and biotinylated monoclonal secondary antibodies were applied. Antibody binding was visualized by using avidin-biotin-peroxidase complexes by subsequent adding 3,3´,5,5´-Tetramethylbenzidine (TMB). Medium was removed 24 hours prior to sampling and 500µl of fresh rASC-medium was added. According to the manufacturer's instructions supernatants were sampled and stored at -20°C for further analysis with ELISA. Assuming a low target protein concentration 1:2 dilutions were prepared and for each ELISA an individual standard curve was prepared. Number of experiments = 4, number of replicates = 6.
Biological activity assay
Rat embryos (12.5 days old) were removed from pregnant females (n=2) under deep terminal ketamine-xylasine anaesthesia and rinsed in fresh Hanks' medium. The thoracic and lumbar dorsal root ganglia (DRG) were carefully dissected and explanted onto Petri dishes filled with medium and incubated with conditioned supernatants of transfected and untransfected rASCs (n=4 for each group), respectively. The supernatants were taken 24 h after transfection of rASCs with pVAX1-rBDNF and pVAX1-mGDNF and stored at -70 °C until further use. The amount of neurotrophic factors in the supernatant was determined by using the ELISA technique and the working concentrations were set to 5 ng/ml. After 24 h incubation with the supernatants the DRGs were carefully washed and photographed under the microscope by using an Olympus DP70 digital camera (Olympus Ltd, Tokyo, Japan). The extent of longitudinal neurite outgrowth was determined in each experimental group through the use of the Image J (NIH) image analysis program.
Ventral root avulsion-reimplantation and transplantation of rASC cells
All together 48 female Sprague-Dawley rats (Animal Research Laboratories, Himberg, Austria, and Animal Facilities at the Faculty of Medicine, University of Szeged, weighing 180-220 g body weight, average age 6 weeks) were used. Twenty-four animals were used for short-term survival studies (5 and 10 days of survival, 4 animals in each group, except control group), 15 rats survived for 3 months following the original operation (n=5 in each group) and 4 intact animals were used to determine the number of motoneurons in the intact L4 segment.
All the operations were carried out under deep ketamine-xylazine anaesthesia (ketamine hydrochloride: 90 mg/kg body weight, Ketavet, Pharmacia & Upjohn Co.; xylazine: 5 mg/kg body weight, Rompun, Bayer Co.) and sterile precautions. To maintain the body temperature at 37.0±0.5°C, the rats were kept on a heating pad during the surgery. Laminectomy was performed at the level of T13-L1 vertebrae, the dura was opened and the left L4 ventral root was pulled out leaving the dorsal roots intact. Then the cut end of the ventral root was inserted into the lateral part of the spinal cord. To avoid damage to the cord, a small hole was created on the lateral surface of the cord, and the avulsed root was inserted into the hole using a watchmaker's forceps (Dumont, Switzerland, No. 5). Special care was taken to avoid damage to the cord, including its motoneuron pool, or to the reimplanted root (Fig. 1C) . The ). The spinal cord was covered with the remaining dura, the wound was closed and the animals were allowed to recover (Pajenda et al. 2013 ).
Animals were sacrificed 10 days or 3 months after the primary operation. The experiments were carried out with the approval of the Animal Protocol Review Board of City Government of Vienna and with that of the Committee for Animal Experiments, University of Szeged and rules regarding the care and use of animals for experimental procedures were followed. All the procedures were carried out according to the Helsinki Declaration on Animal Rights.
Adequate care was taken to minimize pain and discomfort.
Retrograde labelling
Operated animals that survived for 3 months (n=5 in each group) and intact animals (n=4) were deeply reanaesthetized as described above. On the left side the ventral ramus of the L4 spinal nerve was sectioned and the proximal stump of the nerve covered ( 
Cell counts
The number of retrogradely labelled and ChAT positive cells was determined (Fig. 1E) . To avoid double counting of the same neuron present in two consecutive sections, the retrogradely labelled neurons were mapped with the aid of an Olympus (Olympus Ltd, Tokyo, Japan) drawing tube, and their locations were compared to those of labelled neurones in the previous section (Nógrádi et al. 2007 , Pintér et al. 2010 . The proportion of FB+/ChAT+ cells was determined in each experimental group. All sections from the L4 motoneurone pool were used.
Analysis of locomotion pattern -CatWalk gait analysis
To determine and analyze the parameters of the hind limb movement pattern, the 'CatWalk' automated quantitative gait analysis system was used (Noldus Ltd, version 7.1; Wageningen, The Netherlands). Animals were pre-trained once one week before surgery and the cumulative pre-training values representing the parameters of intact animals are included in the diagrams.
This computer-assisted method of locomotor analysis made it possible to quantify several gait parameters, including duration and speed of different phases of the step cycle and print areas detected during locomotion length (Hamers et al., 2001 (Hamers et al., , 2006 . The following parameters were taken into account during the analysis: max. contact area (expressed in mm2): The maximal contact area describes the paw area contacted at the moment of maximal paw-floor contact during the stance phase.
the print area (expressed in mm2): total floor area contacted by the paw during the stance phase.
the mean print intensity (expressed in arbitrary units): the mean pressure exerted by one individual paw during the floor contact.
the stance duration (expressed in s): the stance duration is the time of the stance phase.
the step cycle duration (expressed in s): It represents the time between two consecutive paw placements (stance + swing duration).
Statistical analysis
The t-test and the two-way measurement analysis of variance (ANOVA) computed by using Tukey's all pair-wise multiple comparison procedures or Bonferroni's post hoc test, were used to compare the group data. Non-parametric data were analysed through the use of MannWhitney U test. The various tests were used according to the nature of the data.
Results
In vitro analysis of gene expression
The rASCs transfected with either pVAX-rBDNF or pVAX-mGDNF were kept in culture and supernatants were analyzed through the use of ELISA for their BDNF/GDNF content. Figure   2 shows that the plasmids were able to induce the required time course pattern of protein production: both neurotrophin levels peaked few days after transfection (72h for BDNF and 48h for GDNF, Fig. 2 ) and expression dropped below the 24h levels by 9 days in culture.
These data may suggest that both neurotrophic factors are produced in considerable amounts for approximately 7 days, i.e. during the critical period of motoneuron survival after avulsion injury (Koliatsos 1994 , Nógrádi et al. 2007 ). The neurotrophic factors expression levels, however, displayed differing time course: while BDNF was shown to have a peak expression level at 400% relative to the 24h values and declined by 9 days, GDNF levels reached approximately 250% and dropped back considerably by 9 days, this level of protein expression was maintained till the end of the time-course study (Fig. 2) . Considering absolute values, GDNF expression was always considerably greater than that of BDNF.
Untransfected cells produced negligible amounts of GDNF or BDNF.
Analysis of in vitro biological activity of transfected rASCs
In order to prove that the transfected cells produced biologically potent neurotrophic factors, we performed an in vitro essay. Embryonic dorsal root ganglia were treated with supernatants of BDNF-or GDNF-producing rASCs and their effects was investigated after 24h. Both BDNF and GDNF induced an approximately twofold longitudinal neurite outgrowth compared with the control ganglia that received supernatant of untransfected rASCs.
Interestingly, co-treatment with both BDNF and GDNF, but with identical cumulative neurotrophic factor levels as in the cases of individual treatments did not result in improved neurite outgrowth (Fig. 3 ).
General observations, functional improvement, CatWalk gait analysis system
Behavioral analysis was started 2 weeks after surgery and the first signs of functional recovery were observed 4-5 weeks after reimplantation of the ventral root. Control (group 1, treatment with untransfected rASCs) showed minimal improvement, i.e. their affected hind limb was placed laterally with minimal dorsiflexion of the ankle joint and the spreading reflex was negligible or completely missing. In contrast, animals that received transfected rASC grafts around the reimplanted L4 ventral root (groups 2-4) developed an improving movement pattern similar to that of the intact hind limb. Movements of the ankle joint, especially dorsiflexion was extensive and toe spreading was present. Quantitative gait analysis obtained from the CatWalk automated gait analysis system showed that the earliest differences in functional recovery between these groups appear from week 6 and these differences became significant by week 8 (Fig. 4) . Improved footprint parameters (max. contact area, print area, mean intensity) and dynamic parameters characteristic of the step cycle (stance duration and step cycle duration) showed improved movement pattern in groups 2-4 animals (Fig 4) .
Interestingly, animals that received combined rASC (BDNF+GDNF) grafts (group 4) displayed only slightly, but not significantly better footprint (max. contact area and print area) parameters than the animals treated with either GDNF or BDNF (groups 2 and 3).
Localization of BDNF-and GDNF-transfected cells around the reimplanted ventral root
Rats that received transfected rASCs embedded in collagen matrix placed along the reimplanted ventral root, formed a well-defined tissue cuff around the reimplanted ventral root 10 days after grafting (Fig. 5) . The majority of the grafted rASCs were labelled with CellBrite ( Fig. 5A-B and F-G) and expressed GDNF ( Fig. 5D-E) or BDNF ( Fig. 5I-J) , respectively. None of the grafted cells was found to have migrated into the ventral root and a small gap, thought to be due to fixation, was found between the ventral root and the cuff of grafted rASCs. The Schwann cells within the ventral root also moderately expressed GDNF and BDNF (Fig. 5A and F) .
Retrograde labelling studies, number of reinnervating motoneurons
The number of retrogradely labelled motoneurons, i.e those cells that were able to send their axons into the reimplanted ventral root correlated with the functional data. Control animals that had their ventral root avulsed and reimplanted and received untransfected rASC grafts (group 1) had few reinnervating motoneurons (63 ± 4 SEM, n=5). In contrast, in the spinal cords of group 2 and 3 animals which received a GDNF-rASC or BDNF-rASC grafts, respectively, much more retrogradely labelled motoneurons were found (192 ± 17 SEM vs 187 ± 12 SEM, n=5 each), without significant difference between these two groups (Fig. 6 ).
On the other hand, grafting of mixed populations of GDNF-and BDNF-rASCs around the reimplanted root (group 4, n=5) produced slightly improved results: The numbers of reinnervating cells were 247 ± 24 SEM (Fig. 6 ).
It is expected that reinnervating motoneurons regenerate their axons in an elongative growth pattern following a moderate growth-promoting stimulus. Indeed, axons of reinnervating motoneurons were present in the reimplanted ventral roots in both control and treatment groups, although in differing numbers. Ventral roots of control (group 1) animals contained only few thin neurofilaments-stained fibres compared with the thicker and numerous axons of the intact L4 ventral roots (Fig. 7A-B) while much more thin axons were found in the spinal roots of group 2-4 animals that received transfected rASCs ( Fig. 7C-E) . We found no evidence of collateral sprouting of nerve fiber coil formation within the reimplanted roots suggesting that the temporarily limited release of neurotrophins by the rASCs induced only elongative growth of regenerating axons ( Fig. 7C-E) . Again, combined treatment with both GDNF-and BDNF-rASCs induced no observable difference to treatments with these factors alone.
Analysis of choline acetyltransferase (ChAT) expression in injured and reinnervating motoneurons
Next the localization of ChAT-expressing surviving and Fast Blue-labelled reinnervating cells was compared. In control rats (group 1) the few retrogradely labelled motoneurons in the ventral horn were ChAT immunoreactive, and many ChAT immunoreactive motoneurons were found unlabelled with Fast Blue (Fig. 8A-C) . Stronger colocalization was found in spinal cords of group 2-4 animals, who received transfected rASCs along their reimplanted ventral root. However, in these spinal cords there were still numerous ChAT immunoreactive cells which were not retrogradely labelled (Fig. 8D-L) .
Accordingly, in control animals the proportions of Fast Blue-labelled motoneurons on the operated side compared with that of the ipsilateral ChAT immunoreactive motoneurons were 17% ± 3 (SEM, group 1; Fig. 9 ) and only 5% ± 1 (SEM) of the total L4 motor pool was able to reinnervate the target muscles. In contrast, in animals that received neurotrophic factorreleasing rASCs (group 2-4) 36-to 50% of the total motoneuron pool survived (ChAT+ motoneurons) and 15-20% of that was able to reinnervate (FB-labelled motoneurons, Fig. 9 ).
None of these three treatment groups were significantly different from each other in respect of the proportion of FB+ and ChAT+ motoneuron numbers / total motoneuron pool, but they were statistically different form the control group.
It is noted, that the reinnervating cells in these 3 groups comprised 15, 16, 20% of the intact L4 motoneuron pool (100% ± 14 SEM, n=4), suggesting a moderate reinnervating mechanism. On the other hand, treatment with transfected rASCs improved the ability of surviving motoneurons to reinnervate peripheral targets. While in control animals only approx. 30% of the ChAT+ cells could send their axons into the reimplanted ventral root, in group 2-4 animals this ratio was approximately 40% (Fig. 9 ).
Discussion
Here we have provided evidence that a spatiotemporally controlled expression of the neurotrophic factors BDNF/ GDNF after ventral root avulsion and subsequent reimplantion of the root promotes motoneuron survival and induces elongative axonal growth of the axons with functional reinnervation of the target muscles. Lentiviral vector mediated over expression of GDNF prevents motoneuron death and enhances axonal outgrowth into reimplanted nerve roots. High locally applied concentrations of GDNF caused trapping of growing axons and lead to coil formation (Eggers et al. 2008 ).
The same group has recently made efforts to create a gradient of GDNF in the sciatic nerve after ventral root avulsion and reimplantion using lentiviral vector-mediated expression of GDNF. Sprouting and coil formation of the axons was observed throughout the nerve provided with the GDNF-gradient, even at relatively low concentrations of the lentivirus applied. The size and number of coils increased with the level of GDNF expressed in the peripheral nerve. Moreover, the number of Schwann cells was increased, but the myelination of the axons was severely impaired. The total number of regenerated and surviving motoneurons was not enhanced (Eggers et al. 2013 ).
On the other hand, intrathecal administration of recombinant GDNF after avulsion and reimplantation of the L4 ventral root into the spinal cord enhanced the survival rate of the injured motoneurons, especially when it was applied in combination with riluzole (Bergerot et al. 2004 ).
There are several hypotheses why potent neurotrophic factors, like GDNF and BDNF rescued the injured motoneurons but failed to promote the elongative growth of regenerating axons.
According to the widely accepted view on the mechanism of action of neurotrophic factors, they provide a directional guidance for regenerating injured axons, which is readily observed in in vitro experiments (Tessier-Lavigne and Goodman, 1996) . The failure of in vivo experiments in supporting elongative axonal growth was thought to be due to the high and sustained neurotrophic factor concentrations around the axons.
The possibility that axon trapping is caused by a different mechanism unrelated to the neurotrophic effect of GDNF has been suggested, too. It is argued, that GDNF could have The question can be raised whether the relatively good functional recovery based on moderate morphological reinnervation in the present study could be further improved. In our earlier studies we have shown that administration of riluzole, a compound capable to block presynaptic release of glutamate and to inhibit voltage gated Na + and Ca 2+ channels induced reinnervation of denervated hind limb muscles up to an extent of 67% after a ventral root avulsion injury Vrbová 2001, Nógrádi et al. 2007 ). In vitro evidence has also been provided that riluzole is able to promote neurite growth of sensory ganglion neurons (Shortland et al. 2006) further strengthening the neuroprotective effects of this compound.
Moreover, intraspinal or intraradicular transplantation of the neuroectodermal stem cell line NE-FP-4C (ATCC No.: CRL-2936) resulted in similarly extensive reinnervation of the hind limb muscles after the avulsion and reimplantation of the L4 ventral root (Pajenda et al. 2013) . It is possible that slightly more GDNF or BDNF secreted at the site of injury could further improve the reinnervation by the surviving motoneurones. On the other hand, it could be argued, that increased release of these neurotrophic factors would already induce a trapping effect on the regenerating axons, rather than supporting their elongative growth as seen in the recent study by Eggers et al. (2013) .
It was interesting to find that the combined action of GDNF and BDNF did not induce significantly improved regeneration, suggesting that the combined application of these neurotrophic factors does not generate a synergistic effect in this model.
Further studies are required to be performed in order to elucidate the mechanisms of neurotrophic factors on injured motoneurons and to determine the dose of individual neurotrophic factor that support survival and regeneration of injured motoneurons but do not cause trapping of their regenerating axons. Taking into consideration the extreme sensitivity of these injured neurons to neurotrophic factors it appears likely that only very low doses, applied to the indirect vicinity of the injured axons are able to fulfill these requirements.
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